Fake news on Twitter travels six times faster than real news and reaches far more users according to a study released by researchers at MIT. Can fake news be stopped?
Sascha Segan is the lead analyst for PCMag.com. Segan joins Cheddar to explain why this problem is so rampant and what needs to be done to stop the problem.
Segan explains that falsehoods are a hard problem to deal with unless the platforms, Facebook and Twitter are willing to take responsibility and control the problem.
Segan says lies are so shareable because they can be constructed to be as fun as possible. In his words, "Lies have no boundaries."
In terms of fixing this problem, Segan says Twitter and Facebook need to come to grips with the fact they are publications and they are editors. They need to take responsibilities over their platforms and seek out lies.
Student loan borrowers have the ability to earn retirement funds pegged to their payments – and the company Summer might be bringing it to your workplace.
It might not be what investors want to hear… but bringing down inflation could mean interest rates stay higher for (even) longer. But it's not all downside.
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.